Small Science · 2024 · 11 citations · 42 references
MedicineOncologyRadiation OncologyMolecular OncologyNanomaterialsNanoparticle Drug DeliveryCancer NanomedicineLuminescent MaterialsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineTelomere Biology In CancerCancer NanotherapyCellular RadiosensitivityGold NanostructuresLuminescent NanomaterialsPhotoluminescenceSelf-assembling Peptide NanomaterialsTherapeutic RadiosensitizationTumor Radiosensitivity
Lung cancer cells resistant to radiotherapy present a significant clinical challenge. Stable telomeric structures, maintained by the TRF2 protein, play a critical role in protecting cells from ionizing radiation. Reduced TRF2 expression increases DNA damage and radiosensitivity. We designed a self-assembling system utilizing ultra-small luminescent gold nanoclusters (AuNCs) with radiosensitizing properties, combined with siRNA targeting TRF2. The system forms ≈100 nm non-spherical structures with AuNCs enriched in the outer layer, exhibiting a 17.6-fold enhancement in red photoluminescence due to aggregation-induced effects. This nanoplatform efficiently penetrates lung cancer cells, reducing TRF2 expression by 50%. Under 5 Gy radiotherapy, cells treated with this system show a 1.5-fold radiosensitivity increase from AuNCs and a 2.3-fold reduction in clonogenic survival due to telomere deprotection. The AuNC-siRNATRF2 system combines enhanced optical properties with biological functionality, offering a promising approach to augment radiotherapy efficacy by disrupting telomeric protective mechanisms in cancer cells.
42
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians · 2016 · 6.2K citations · Full text